Results from the randomized controlled TARGET FFR trial show that while a physiology-guided percutaneous coronary intervention (PCI) optimization strategy did not achieve a significant increase in the proportion of patients with final FFR ?0.90, it reduced the proportion of patients with a residual FFR ?0.80 following PCI.
- UMD-led study shows fear and anxiety share same bases in brain
- Patients who had more severe covid-19 may be the best donors for convalescent plasma therapy
- Astrophysics team lights the way for more accurate model of the universe
- Tropical cyclones moving faster in recent decades
- Untreated sleep apnea is associated with flu hospitalization